Cargando…
Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
BACKGROUND: Although chronic urticaria (CU) is a common, cause of medical consulting both in general practitioners and allergist specialists worldwide, there is little information about its behavior and management in Latin America. Currently, national and international guidelines recommend using Oma...
Autores principales: | García-Gómez, Elizabeth, Chapman, Edgardo, García-Paba, María Beatriz, Ocampo-Gómez, Jaime, Egea-Bermejo, Eduardo, Garavito-De Egea, Gloria, Fang, Luis, Sarrazola, Mauricio, Sánchez-Caraballo, Jorge Mario, Serrano-Reyes, Carlos, Silva-Espinosa, Diana Lucia, Rojas-Mejía, Dolly Vanessa, Moreno, Sergio M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234875/ https://www.ncbi.nlm.nih.gov/pubmed/35769574 http://dx.doi.org/10.3389/falgy.2022.902344 |
Ejemplares similares
-
Efficacy and safety of omalizumab therapy in urticaria vasculitis
por: Petrelli, Fiorella, et al.
Publicado: (2022) -
Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous Urticaria
por: Ridge, Katie, et al.
Publicado: (2021) -
269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012) -
Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review
por: Carrillo, Diana C, et al.
Publicado: (2014) -
274 Vasculitic Urticaria Treated with Omalizumab. Case Report
por: Ramírez Del Pozo, María Elena, et al.
Publicado: (2012)